MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel Moves

Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel Moves

By

Clearpath Robotics snags Intuitive Surgical design guru Hanuschik | Personnel MovesSelf-driving vehicle development company Clearpath Robotics said today it picked up Intuitive Surgical‘s (NSDQ:ISRG) director of design & management Mike Hanuschik.

Hanuschik led the design and product management for Intuitive Surgical’s flagship da Vinci surgical robot system, the market leading robotic surgery platform. The da Vinci is used in over 500,000 procedures annually, according to the company.

“Mike has a proven track record of building world-class teams and developing complex robot systems that are well adopted. He is an inspiring leader who knows how to create and execute an ambitious vision.  We couldn’t be more excited to have him join our executive team,” CEO Matt Rendall said in a press release.

Hanuschik started at Intuitive Surgical with no formal design education, according to a Print Magazine interview.

After leaving his job in the Navy, where he spent his time repairing displays and interfaces for fighter jets, Hanuschik found himself at a job fair Intuitive Surgical was attending. According to Hanuschik, he was offered a choice of either working on the da Vinci system, or on batteries.

He started with the Sunnyvale, Calif.-based company as a product support engineer, moving through product management to become design and management director for the da Vinci system.

Clearpath has tagged Hanuschik as its chief product officer, and said he will help establish and grow Clearpath’s Silicon Valley product design office.

“The 1st thing that stands out about Clearpath is the people. When you walk around the company, there’s a palpable sense of excitement about the work they are doing and it shows in the quality of the products they create. They clearly know how to have fun yet maintain high standards of craftsmanship and a heightened sense of urgency,” Hanuschik said.

 

 JenaValve taps Wulff for CFO
JenaValve said yesterday it has snagged ex-Pure Biosciences CFO and COO Peter Wulff for its new CFO, joining ex-Boston Scientific (NYSE:BSX) general manager Victoria Carr-Brendel who took the reins as CEO in June.
Read more

 St. Jude names Zimmer Biomet’s Dvorak to board
St. Jude Medical (NYSE:STJ) said today it has added Zimmer Biomet‘s (NYSE:ZBH) president and CEO David Dvorak to its board of directors, effective August 4.
Read more

 Ex-AxoGen exec Schiaparelli lands CEO job at Intelomed
InteloMed has named Jill Shiaparelli as its new CEO. Shiaparelli left her position as chief medical officer at AxoGen Inc. (NSDQ:AXGN) in June, to join an at-the-time ‘unnamed’ medical tech company as CEO.
Read more

 Nu-Med Plus adds Merrell as CFO
Nu-Med Plus said yesterday it tagged 30-year accounting vet Kenneth Merrell as its new CFO, replacing outgoing Mark Christensen.
Read more

 Iridex CFO Mackaness steps down
Iridex (NSDQ:IRIX) said yesterday its CFO James Mackaness, who has been with the company since 2008, has stepped down to accept a position as CFO of a different, unnamed company.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • EPA delayed notifying residents of ethylene oxide emissions
    The EPA delayed notifying neighbors of an Illinois medical device sterilization plant of ethylene oxide (EtO) emissions the agency measured in 2018, according to an inspector general’s report released yesterday. The report also says that “leadership” in the agency’s Office of Air and Radiation also failed to conduct public meetings with residents either near the… […]
  • 9 medical devices you should keep an eye out for in 2021
    The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek… […]
  • Greenlight Guru to provide QMS to NIH diagnostics program
    NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]
  • MicroCare names CFO
    MicroCare (New Britain, Conn.) has announced the appointment of John Stardellis as the company’s new chief financial officer (CFO). Stardellis joins MicroCare with more than 20 years’ experience in a variety of finance, policy and operational leadership roles. Most recently, he served as CFO at i-Health, a division of DSM Nutritional Products. “John’s track record with… […]
  • Mayo Clinic helps launch two new companies for improved diagnostics
    Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. Get the full story… […]
  • Intertek gains FDA nod for premarket device testing
    Intertek has won accreditation under an FDA pilot program for testing laboratories, the company said this week. The accreditation authorizes Intertek’s 12 “medical centers of excellence” to perform premarket testing of devices for the U.S. market. The Accreditation Scheme for Conformity Assessment pilot program is a voluntary program developed to provide increased confidence in testing… […]
  • HHS shoots down ‘flawed’ plan to let some devices skip review
    The Biden administration has nixed what it described as a “flawed” Trump-era decision to exempt certain medical devices — including infusion pump controllers and fetal monitors — from regulatory review. HHS published the original notice in the Federal Register on Jan. 15, shortly before President Joe Biden was set to take office, without speaking with… […]
  • More than 50 medtech testing sites win FDA pilot accreditation
    The FDA announced today that more than 50 laboratory sites were chosen to participate in its program for streamlined regulatory reviews. In total, 53 sites made the FDA’s initial list for participation in its Accreditation Scheme for Conformity Assessment (ASCA) program, which will set out to support more streamlined regulatory reviews of medical device market… […]
  • Medline Industries up for sale?
    Medline Industries is looking for a buyer in a deal that could be worth $30 billion, according to a report in the Wall Street Journal. The Journal cites “people familiar with the matter” saying that Northfield, Ill.-based Medline has hired Goldman Sachs to manage the process. The people added that the company might alternatively seek… […]
  • Micro to add plant in Costa Rica
    Contract manufacturer Micro today announced plans to open a new plant in Costa Rica. The 32,000 ft² facility will significantly increase Micro’s cleanroom assembly capacity, according to the Somerset, N.J.-based company. It will be located in the Zona Franca Metro business park and is expected to open in late 2021 with operations beginning in 2022.… […]
  • Survey shows solid medical device industry performance despite pandemic
    By Stewart Eisenhart, Emergo Group Medical device and IVD manufacturers report healthy performance over the course of 2020, but also faced significant operational and regulatory challenges related to the coronavirus pandemic. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not… […]